Role of plasminogen activator-plasmin system in tumor angiogenesis

Cell Mol Life Sci. 2003 Mar;60(3):463-73. doi: 10.1007/s000180300039.


New blood formation or angiogenesis has become a key target in therapeutic strategies aimed at inhibiting tumor growth and other diseases associated with neovascularization. Angiogenesis is associated with important extracellular remodeling involving different proteolytic systems among which the plasminogen system plays an essential role. It belongs to the large serine proteinase family and can act directly or indirectly by activating matrix metalloproteinases or by liberating growth factors and cytokines sequestered within the extracellular matrix. Migration of endothelial cells is associated with significant upregulation of proteolysis and, conversely, immunoneutralization or chemical inhibition of the system reduces angiogenesis in vitro. On the other hand, genetically altered mice developed normally without overt vascular anomalies indicating the possibility of compensation by other proteases in vivo. Nevertheless, they have in some experimental settings revealed unanticipated roles for previously characterized proteinases or their inhibitors. In this review, the complex mechanisms of action of the serine proteases in pathological angiogenesis are summarized alongside possible therapeutic applications.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Fibrinolysin / metabolism*
  • Genetic Vectors
  • Humans
  • Neovascularization, Pathologic / metabolism*
  • Plasminogen / metabolism
  • Plasminogen Activator Inhibitor 1 / metabolism
  • Plasminogen Activators / metabolism*
  • Signal Transduction / physiology
  • Viruses


  • Plasminogen Activator Inhibitor 1
  • Plasminogen
  • Plasminogen Activators
  • Fibrinolysin